Introduction
Cardiovascular Drug Market was valued at USD XX Billion in 2019 and is projected to reach USD XX billion by 2025, at a CAGR of XX% from 2020-2025. Cardiovascular Diseases are commonly known as heart diseases. These diseases are mainly associated with the circulatory system and heart. Increasing cardiovascular diseases so rapidly is because of the changing lifestyle of the population. Being trendy and getting everything in hand and at the doorstep, making people lazy towards the work, which leads to obesity, diabetes and blood pressure problems. These are the main components of the cardiovascular diseases. Now-a-days even the teenagers are facing the blood pressure problems.
Increasing unhealthy population and the existence of rare new drugs in the clinical studies are additional factors that help in the boosting the growth of global cardiovascular drug market. Development of new therapeutics and greater awareness with improved understanding of cardio diseases have been contributing in the introduction of new cardiovascular medications.
Geographical Overview
At a global level, the North America region was holding the highest market share in 2019. Due to increase in the research and development of the rare therapeutics and the awareness for the healthy lifestyle is witnessing the growth in the region. Asia Pacific is expecting to have a highest market value growth due to its awareness of health and the improved healthcare structures. Europe is driving the growth and expecting a rapid increase in the cardiovascular drug market. The Middle East and Africa can expect a steady growth in the future.
Segmental Overview
Cardiovascular Drug Market is segmented as per below specifications -
By Drug Type:
• Antihypertensive
• Antihyperlipidemic
• Anticoagulants
• Antiplatelet Drugs
• Others
By Disease Indication:
• Hypertension
• Hyperlipidemia
• Coronary Artery Disease
• Arrhythmia
• Others
By Distribution Channel:
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
Competitor Analysis
Cardiovascular Drug Market has presence of some of the key major players across globe which includes
• Bristol-Myers Squibb Co.
• Pfizer Inc.
• Bayer AG
• Janssen Pharmaceuticals Inc.
• Sanofi
• Novartis AG
• Merck & Co. Inc.
• Gilead Sciences Inc.
• F. Hoffmann-La Roche Ltd
• Johnson&Johnson
• Roche Holding AG
• Astellas Pharma Inc.
These key players are concentratingits efforts on the continuous product improvement with innovative initiatives to have an edge over other competitors. Further, to garner maximum market share,companies are adoptingmerger/ acquisition/ partnership and maintaining strong distribution networks strategies.
By Geographical Locations:
• North America
o U.S.
o Canada
• Europe
o U.K.
o France
o Italy
o Germany
o Spain
o Russia & CIS
o Rest of Europe
• Asia-Pacific
o China
o India
o Japan
o South Korea
o ASEAN
o Rest of Asia Pacific
• Latin America
o Brazil
o Argentina
o Rest of LATAM
• Middle East & Africa
o UAE
o South Africa
o Rest of MEA
Highlights of the report
What is Cardiovascular Drug Market?
Who all are key market players in the industry?
How the Parent Industry is growing?
Where are the key opportunities for new market entrant?
A comprehensive analysis, which covers key growth factors across the value chain
Recent developments in market
Granular Market Segmentation
Market size projection based on Historical & current market trends
Market share analysis and key strategies adopted by leadingPlayers
Production Cost & Sensitivity Analysis
Country Level Market Analysis of Top 16 countries
Data Driven Decision Recommendations
Chapter 1 Research Objective
1.1 Need of the Research Report
1.2 Client Objectives
1.3 Offered Solutions
Chapter 2 Recommendations
2.1 Executive Summary
2.1.1 Market Overview
2.1.2 Competitive Insights
2.1.3 Segmental Analysis
2.1.4 Geographical Market Details
2.2 Lead Generation
2.3 Consultant
2.4 Return on Investment
Chapter 3 Research Methodology
3.1 Chromatus Database
3.2 Paid Sources
3.3 Primary Data Collection
3.3.1 Email Surveys
3.3.2 Telephonic Interviews
3.3.3 Face to Face Interviews
3.4 Secondary Data Collection
3.4.1 Annual Reports
3.4.2 Government Publications
3.4.3 Trade Data
3.4.4 Association Data
3.4.5 Research Papers/ Blogs/ News Articles
3.5 Expert Advisory Panel
3.6 Data Analytics Model
Chapter 4 Cardiovascular Drug Market Overview
4.1 Parent Market Overview
4.2 Patent Analysis
4.3 PESTEL Analysis
4.3.1 Political
4.3.2 Economical
4.3.3 Social
4.3.4 Technological
4.3.5 Legal
4.4 SWOT Analysis
4.4.1 Strengths
4.4.2 Weakness
4.4.3 Opportunities
4.4.4 Threats
4.5 Regulations
4.6 Value Chain/ Supply Chain Analysis
4.7 Procurement & Vendor Analysis
4.8 Porters Five Analysis
4.8.1 Threat of new entrants
4.8.2 Bargaining power of suppliers
4.8.3 Bargaining power of buyers
4.8.4 Threat of substitutes
4.8.5 Competitive rivalry
Chapter 5 Regional Analysis
Global Cardiovascular Drug Market Estimation and Forecast, 2017 - 2025 (USD Billion)
5.1 North America Market
5.1.1 U.S.
5.1.1 Canada
5.2 Europe Market
5.2.1 UK
5.2.2 Germany
5.2.3 France
5.2.4 Spain
5.2.5 Italy
5.2.6 Russia& CIS
5.2.7 Rest of Europe
5.3 Asia Pacific Market
5.3.1 China
5.3.2 Japan
5.3.3 India
5.3.4 South Korea
5.3.5 ASEAN
5.3.6 Rest of Asia Pacific
5.4 Rest of the World
5.4.1 Latin America
5.4.1.1 Brazil
5.4.1.2 Argentina
5.4.1.3 Rest of Latin America
5.4.2 Middle East
5.4.3 Africa
Chapter 6 Company Profile
6.1 Pfizer Inc.
6.1.1 Introduction
6.1.2 Financial Overview
6.1.3 Product Portfolio
6.1.4 Recent Developments
6.1.5 SWOT Analysis
6.2 Bristol-Myers Squibb Co.
6.3 Bayer AG
6.4 Janssen Pharmaceuticals Inc.
6.5 Sanofi
6.6 Novartis AG
6.7 Merck & Co. Inc.
6.8 Gilead Sciences Inc.
6.9 F. Hoffmann-La Roche Ltd.
6.10 Astellas Pharma Inc.
Chapter 7 Competitor Analysis
7.1 Company Ranking
7.2 Key Innovators
7.3 Market Leader
7.4 Emerging Players
7.5 Strategic Alliances
7.6 Competitive Matrix of 12 Companies
Chapter 8 Global Cardiovascular Drug Market by Drug Type Estimation and Forecast, 2017 - 2025 (USD Billion)
8.1 Antihypertensive
8.2 Antihyperlipidemic
8.3 Anticoagulants
8.4 Others
Chapter 9 Global Cardiovascular Drug Market by Disease Type Estimation and Forecast, 2017 - 2025 (USD Billion)
9.1 Hypertensive
9.2 Hyperlipidemic
9.3 Coronary Artery Disease
9.4 Arrhythmia
Chapter 10 Global Cardiovascular Drug Market by Distribution Channel Estimation and Forecast, 2017 - 2025 (USD Billion)
10.1 Hospital Pharmacies
10.2 Retail Pharmacies
10.3 Online Pharmacies
Chapter 11 Appendix
11.1 Data Sources
11.2 Abbreviations
11.3 About US
11.4 Disclaimer
11.5 Key Notes
List of Tables
Table 1 Global Cardiovascular Drug Market, by Region, 2017 - 2025 (USD Billion)
Table2 Global Cardiovascular Drug Market, by Product Type, 2017 - 2025 (USD Billion)
Table3 Global Cardiovascular Drug Market, by Consumption Type, 2017 - 2025 (USD Billion)
Table4 Global Cardiovascular Drug Market, by Distribution Type, 2017 - 2025 (USD Billion)
Table5North America Cardiovascular Drug Market2017 - 2025 (USD Billion)
Table6North America Cardiovascular Drug Market by Product Type 2017 - 2025 (USD Billion)
Table7North America Cardiovascular Drug Market by Consumption Type 2017 - 2025 (USD Billion)
Table8North America Cardiovascular Drug Market by Distribution Type 2017 - 2025 (USD Billion)
Table9US Cardiovascular Drug Market2017 - 2025 (USD Billion)
Table10Canada Cardiovascular Drug Market2017 - 2025 (USD Billion)
Table11Europe Cardiovascular Drug Market2017 - 2025 (USD Billion)
Table12Europe Cardiovascular Drug Market by Product Type 2017 - 2025 (USD Billion)
Table13Europe Cardiovascular Drug Market by Consumption Type 2017 - 2025 (USD Billion)
Table14Europe Cardiovascular Drug Market by Distribution Type 2017 - 2025 (USD Billion)
Table15 UK Cardiovascular Drug Market2017 - 2025 (USD Billion)
Table16GermanyCardiovascular Drug Market2017 - 2025 (USD Billion)
Table17France Cardiovascular Drug Market2017 - 2025 (USD Billion)
Table18Spain Cardiovascular Drug Market2017 - 2025 (USD Billion)
Table19ItalyCardiovascular Drug Market2017 - 2025 (USD Billion)
Table20Russia& CISCardiovascular Drug Market2017 - 2025 (USD Billion)
Table21Rest of Europe Cardiovascular Drug Market2017 - 2025 (USD Billion)
Table22Asia Pacific Cardiovascular Drug Market2017 - 2025 (USD Billion)
Table23Asia Pacific Cardiovascular Drug Market by Product Type 2017 - 2025 (USD Billion)
Table24Asia Pacific Cardiovascular Drug Market by Consumption Type 2017 - 2025 (USD Billion)
Table25Asia Pacific Cardiovascular Drug Market by Distribution Type 2017 - 2025 (USD Billion)
Table26ChinaCardiovascular Drug Market2017 - 2025 (USD Billion)
Table27Japan Cardiovascular Drug Market2017 - 2025 (USD Billion)
Table28IndiaCardiovascular Drug Market2017 - 2025 (USD Billion)
Table29South KoreaCardiovascular Drug Market2017 - 2025 (USD Billion)
Table30ASEAN Cardiovascular Drug Market2017 - 2025 (USD Billion)
Table31Rest of Asia Pacific Cardiovascular Drug Market2017 - 2025 (USD Billion)
Table32Latin America Cardiovascular Drug Market2017 - 2025 (USD Billion)
Table33Latin America Cardiovascular Drug Market by Product Type 2017 - 2025 (USD Billion)
Table34Latin America Cardiovascular Drug Market by Consumption Type 2017 - 2025 (USD Billion)
Table35Latin America Cardiovascular Drug Market by Distribution Type 2017 - 2025 (USD Billion)
Table36 Brazil Cardiovascular Drug Market2017 - 2025 (USD Billion)
Table37 Argentina Cardiovascular Drug Market2017 - 2025 (USD Billion)
Table38 Rest of Latin America Cardiovascular Drug Market2017 - 2025 (USD Billion)
Table39Middle EastCardiovascular Drug Market2017 - 2025 (USD Billion)
Table40 Middle East Cardiovascular Drug Market by Product Type 2017 - 2025 (USD Billion)
Table41Middle East Cardiovascular Drug Market by Consumption Type 2017 - 2025 (USD Billion)
Table42Middle East Cardiovascular Drug Market by Distribution Type 2017 - 2025 (USD Billion)
Table43Africa Cardiovascular Drug Market2017 - 2025 (USD Billion)
Table44 Africa Cardiovascular Drug Market by Product Type 2017 - 2025 (USD Billion)
Table45Africa Cardiovascular Drug Market by Consumption Type 2017 - 2025 (USD Billion)
Table46Africa Cardiovascular Drug Market by Distribution Type 2017 - 2025 (USD Billion)
List of Figures
Fig. 1 Primary Research Method
Fig. 2 Secondary Research Method
Fig. 3 Value chain analysis
Fig. 4 PESTEL Analysis
Fig. 5 SWOT Analysis
Fig. 6 Porters Five forces analysis
Fig. 7 Cardiovascular Drug Market: Penetration & growth prospect mapping
Fig. 8 Cardiovascular Drug Market: Competitive snapshot
Fig. 9 Cardiovascular Drug Market: Segmental snapshot
Fig. 10 Market Overview
Fig. 11 Cardiovascular Drug Market: Product Analysis, 2017- 2025
Fig. 12 Cardiovascular Drug Market: Regional Analysis, 2017- 2025
Fig. 13 Cardiovascular Drug Market: Competitive Matrix
Fig. 14 Cardiovascular Drug Market: Revenue Mix